VAI Trademark

Trademark Overview

On Friday, August 13, 2021, a trademark application was filed for VAI with the United States Patent and Trademark Office. The USPTO has given the VAI trademark a serial number of 90882005. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Antares Pharma, Inc.. The VAI trademark is filed in the Medical Instrument Products category with the following description:

injection device for pharmaceuticals and biopharmaceuticals
vai

General Information

Serial Number90882005
Word MarkVAI
Filing DateFriday, August 13, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements

Goods and Servicesinjection device for pharmaceuticals and biopharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 4, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAntares Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameAntares Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628

Trademark Events

Event DateEvent Description
Monday, October 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 17, 2021NEW APPLICATION ENTERED
Tuesday, May 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 14, 2022ASSIGNED TO EXAMINER
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 16, 2023SOU EXTENSION 1 FILED
Thursday, February 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 16, 2023SOU EXTENSION 2 FILED
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Saturday, February 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 4 GRANTED
Wednesday, August 14, 2024SOU EXTENSION 4 FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 13, 2024SOU EXTENSION 3 FILED

Related Keywords

biopharmaceuticals pharmaceuticals device injection